neuropathic pain

pain management pain
Biotech

Lexicon feels the pain as non-opioid data underwhelm investors

The biotech focused on low-dose results, rather than the overall primary endpoint miss, but investors took a much more downbeat view of the data.
Nick Paul Taylor Mar 3, 2025 9:52am
pain management pain

Vertex passes neuropathic pain test, teeing up pivotal trials

Dec 13, 2023 7:52am
An artists concept of spinal pain A silhouette of a person stands holding their back The spinal cord is highlighted on the

Gene therapy reduces chronic pain and chemo-induced neuropathy

Jul 31, 2023 9:30am
Graphic of employees walking out depicting layoffs

Sangamo lays off 27% of US staff in latest refocus

Apr 27, 2023 8:55am
bullseye darts target

Lexicon misses mark in phase 2 pain trial

Dec 22, 2022 10:26am
Back Pain

Non-opioid pain drug indirectly blocks a key ion channel

Nov 10, 2021 2:00pm